share_log

Plus Therapeutics | 8-K: Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

SEC ·  Mar 6, 2024 05:13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more